EVIDENCE TAKEAWAY
The short answer.
Interest in BPC-157 is driven by broad preclinical findings. The central evidence gap is not whether animal signals exist, but whether a defined product is safe and effective in people.
WHAT IS BPC-157?
Start with identity.
A synthetic 15-amino-acid research peptide with extensive preclinical claims but little interpretable human efficacy evidence.
- Entity type
- Synthetic peptide
- Research category
- Recovery
- Names and aliases
- BPC-157
HUMAN VS PRECLINICAL
What evidence exists for BPC-157?
No completed Phase II efficacy program and no reliable basis for routine clinical claims.
A large animal and laboratory literature has not yet translated into established human benefit.
RESEARCH INTENT
What is BPC-157 being studied for?
Current source-backed research areas include the topics below. Inclusion means the area is being investigated; it does not establish a treatment benefit.
- 01Tissue repair
- 02Gastrointestinal models
- 03Inflammation
- 04Angiogenesis
U.S. REGULATORY STATUS
Is BPC-157 FDA approved?
Not FDA approved; FDA identifies important compounding safety and characterization concerns.
SPORT STATUS
Is BPC-157 prohibited in sport?
Prohibited at all times under the 2026 WADA List (S0).
Anti-doping rules and product ingredients can change. Athletes should verify the current official list and the exact product before making a real decision.
EVIDENCE LIMITS
What can the current record not establish?
COMMON SEARCH INTENTS
Reviewed questions about BPC-157.
What is the evidence for BPC-157?
Interest in BPC-157 is driven by broad preclinical findings. The central evidence gap is not whether animal signals exist, but whether a defined product is safe and effective in people.
3 sources ResearchWhat is BPC-157 being studied for?
Current source-backed research areas include Tissue repair, Gastrointestinal models, Inflammation, Angiogenesis. These areas describe investigation, not established personal benefit.
3 sources FDA statusIs BPC-157 FDA approved?
Current U.S. status for BPC-157: Not FDA approved; FDA identifies important compounding safety and characterization concerns.
3 sources Sport statusIs BPC-157 prohibited in sport?
Current sport-status snapshot for BPC-157: Prohibited at all times under the 2026 WADA List (S0).
3 sources Evidence limitsWhat are the main evidence limits for BPC-157?
Commercial descriptions often translate animal findings into human recovery claims. The evidence does not support that shortcut.
3 sources Decision questionWhat is the evidence for BPC-157 and TB-500?
Both are promoted for recovery far beyond the human evidence. The main differences are the shape of the preclinical literature and the identity problem around TB-500.
4 sourcesPRIMARY AND OFFICIAL SOURCES